Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, December 29, 2022
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
[ Thu, Dec 29th 2022
] - WOPRAI
Wed, December 28, 2022
[ Wed, Dec 28th 2022
] - WOPRAI
[ Wed, Dec 28th 2022
] - WOPRAI
[ Wed, Dec 28th 2022
] - WOPRAI
[ Wed, Dec 28th 2022
] - WOPRAI
[ Wed, Dec 28th 2022
] - WOPRAI
[ Wed, Dec 28th 2022
] - WOPRAI
Tue, December 27, 2022
[ Tue, Dec 27th 2022
] - WOPRAI
[ Tue, Dec 27th 2022
] - WOPRAI
Fri, December 23, 2022
[ Fri, Dec 23rd 2022
] - WOPRAI
[ Fri, Dec 23rd 2022
] - WOPRAI
[ Fri, Dec 23rd 2022
] - WOPRAI
[ Fri, Dec 23rd 2022
] - WOPRAI
[ Fri, Dec 23rd 2022
] - WOPRAI
[ Fri, Dec 23rd 2022
] - WOPRAI
[ Fri, Dec 23rd 2022
] - WOPRAI
Thu, December 22, 2022
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
[ Thu, Dec 22nd 2022
] - WOPRAI
Kristen Kluska Initiated (XFOR) at Buy and Held Target at $3 on, Dec 22nd, 2022
Kristen Kluska of Cantor Fitzgerald, Initiated "X4 Pharmaceuticals, Inc." (XFOR) at Buy and Held Target at $3 on, Dec 22nd, 2022.
Kristen has made no other calls on XFOR in the last 4 months.
There are 2 other peers that have a rating on XFOR. Out of the 2 peers that are also analyzing XFOR, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kristen
- Edward Tenthoff of "Piper Sandler" Initiated at Buy and Held Target at $3 on, Monday, December 12th, 2022
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5 on, Wednesday, November 30th, 2022
